BIOMAT Database Logo BIOMAT Database Logo

[Atopic dermatitis in adults during the COVID-19 pandemic]. 2023

Laura Sinai Parra-Jaramillo, and Adriana Ramírez-Rico, and Martha Alejandra Morales-Sánchez
Centro Dermatológico Dr. Ladislao de la Pascua, Servicios de Salud Pública de la Ciudad de México.

OBJECTIVE To evaluate the clinical course of atopic dermatitis (AD) in adults during the COVID-19 pandemic and to evaluate their comorbidities and cardiovascular risk. METHODS A cross-sectional study was conducted in adults with AD. Severity and control of AD, quality of life, levels of psychological stress, depression and cardiovascular risk were measured. RESULTS Forty-two patients were included. A decrease in POEM score (11.83 vs 10.12; p=0.004) and PO-SCORAD (37.77 vs 32.49; p= 0.001) was observed in comparison to the scores at pandemic onset. The quality of life correlated with the severity of AD (p<0.0001) while the levels of stress and depression did not show association. Most patients had a low cardiovascular risk. CONCLUSIONS The results suggest a decrease in the current severity of AD compared with severity before pandemic. Quality of life is associated with AD severity.

UI MeSH Term Description Entries
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D003876 Dermatitis, Atopic A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. Eczema, Atopic,Eczema, Infantile,Neurodermatitis, Atopic,Neurodermatitis, Disseminated,Atopic Dermatitis,Atopic Eczema,Atopic Neurodermatitis,Disseminated Neurodermatitis,Infantile Eczema
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D058873 Pandemics Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people. Pandemic

Related Publications

Laura Sinai Parra-Jaramillo, and Adriana Ramírez-Rico, and Martha Alejandra Morales-Sánchez
Optimizing care for atopic dermatitis patients during the COVID-19 pandemic.
August 2020, Journal of the American Academy of Dermatology,
Laura Sinai Parra-Jaramillo, and Adriana Ramírez-Rico, and Martha Alejandra Morales-Sánchez
Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients.
February 2022, International journal of environmental research and public health,
Laura Sinai Parra-Jaramillo, and Adriana Ramírez-Rico, and Martha Alejandra Morales-Sánchez
Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic.
September 2020, Journal of the American Academy of Dermatology,
Laura Sinai Parra-Jaramillo, and Adriana Ramírez-Rico, and Martha Alejandra Morales-Sánchez
Navigating patients with atopic dermatitis or chronic spontaneous urticaria during the COVID-19 pandemic.
January 2022, Frontiers in allergy,
Laura Sinai Parra-Jaramillo, and Adriana Ramírez-Rico, and Martha Alejandra Morales-Sánchez
[Impact of COVID-19 Pandemic on Patients with Atopic Dermatitis].
March 2022, Actas dermo-sifiliograficas,
Laura Sinai Parra-Jaramillo, and Adriana Ramírez-Rico, and Martha Alejandra Morales-Sánchez
Impact of COVID-19 Pandemic on Patients with Atopic Dermatitis.
March 2022, Actas dermo-sifiliograficas,
Laura Sinai Parra-Jaramillo, and Adriana Ramírez-Rico, and Martha Alejandra Morales-Sánchez
Comments on metabolomics in asthma and atopic dermatitis, and patient care during the COVID-19 pandemic.
November 2021, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology,
Laura Sinai Parra-Jaramillo, and Adriana Ramírez-Rico, and Martha Alejandra Morales-Sánchez
Impact of the COVID-19 Pandemic on Adult Patients with Atopic Dermatitis.
August 2023, Acta dermatovenerologica Croatica : ADC,
Laura Sinai Parra-Jaramillo, and Adriana Ramírez-Rico, and Martha Alejandra Morales-Sánchez
Atopic dermatitis patient perspectives on dupilumab therapy during the COVID-19 pandemic: an international survey study.
November 2021, Dermatology online journal,
Laura Sinai Parra-Jaramillo, and Adriana Ramírez-Rico, and Martha Alejandra Morales-Sánchez
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry.
June 2021, Allergy,
Copied contents to your clipboard!